Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression.

Rupp J, Berger M, Reiling N, Gieffers J, Lindschau C, Haller H, Dalhoff K, Maass M.

Biochem Biophys Res Commun. 2004 Jul 30;320(3):738-44.

PMID:
15240110
2.

Production of prostaglandin E2 in monocytes stimulated in vitro by Chlamydia trachomatis, Chlamydophila pneumoniae, and Mycoplasma fermentans.

Krausse-Opatz B, Schmidt C, Fendrich U, Bialowons A, Kaever V, Zeidler H, Kuipers J, Köhler L.

Microb Pathog. 2004 Sep;37(3):155-61.

PMID:
15351039
3.

Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.

Ito H, Duxbury M, Benoit E, Farivar RS, Gardner-Thorpe J, Zinner MJ, Ashley SW, Whang EE.

Biochem Biophys Res Commun. 2004 May 28;318(2):594-600.

PMID:
15120641
4.

Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.

Ito H, Duxbury M, Benoit E, Clancy TE, Zinner MJ, Ashley SW, Whang EE.

Cancer Res. 2004 Oct 15;64(20):7439-46.

6.

Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.

Repasky GA, Zhou Y, Morita S, Der CJ.

Mol Carcinog. 2007 Dec;46(12):958-70.

PMID:
17477350
7.
8.

Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.

Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, Friedman SL.

J Hepatol. 2004 Aug;41(2):251-8.

PMID:
15288474
9.
10.

Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.

Lin CC, Lin WN, Wang WJ, Sun CC, Tung WH, Wang HH, Yang CM.

Cardiovasc Res. 2009 Jun 1;82(3):522-31. doi: 10.1093/cvr/cvp069. Epub 2009 Feb 20.

PMID:
19233864
11.

Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro.

Kankuri E, Solatunturi E, Vapaatalo H.

Thromb Res. 2003 Jun 15;110(5-6):299-303.

PMID:
14592552
12.
14.

Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.

Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.

Clin Cancer Res. 2004 Jul 15;10(14):4670-9.

15.

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.

Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A.

Circulation. 2001 Aug 21;104(8):921-7.

PMID:
11514380
16.

Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells.

Mayoral R, Fernández-Martínez A, Boscá L, Martín-Sanz P.

Carcinogenesis. 2005 Apr;26(4):753-61. Epub 2005 Jan 20.

PMID:
15661807
17.
18.
19.

n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.

Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P.

Carcinogenesis. 2004 Dec;25(12):2303-10. Epub 2004 Sep 9.

PMID:
15358633
20.

PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells.

Shio MT, Ribeiro-Dias F, Timenetsky J, Jancar S.

Exp Cell Res. 2004 Aug 1;298(1):296-304.

PMID:
15242784

Supplemental Content

Support Center